Netherlands Analysis

Industry Trend Analysis - Further Medicine Price Cuts Are Inevitable - APR 2014

Despite expectations for a return to positive economic growth in 2014, the Dutch government will persist with austerity measures to comply with the EU's budget criteria. We therefore maintain that further restrictions on medicines prices under the Medicines Prices Act, which actually came into force long before the Eurozone debt crisis, will work to create a subdued outlook for patented and...

READ FULL ARTICLE